Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ENVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -5.864M
March 31, 2026 -2.503M
December 31, 2025 -2.689M
September 30, 2025 -2.992M
June 30, 2025 -0.4491M
March 31, 2025 -4.449M
December 31, 2024 -0.302M
September 30, 2024 -0.5178M
June 30, 2024 -0.0517M
March 31, 2024 -6.802M
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 1.052M
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 -7.824M
June 30, 2022 0.00
March 31, 2022 -9.398M
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 -0.0179M
March 31, 2021 -24.88M
September 30, 2020 -0.2275M
June 30, 2020 0.00
March 31, 2020 0.00
Date Value
December 31, 2019 0.00
September 30, 2019 -0.0002M
June 30, 2019 -0.6558M
March 31, 2019 -1.468M
December 31, 2018 -0.0193M
September 30, 2018 -5.680M
June 30, 2018 -0.0092M
March 31, 2018 -0.619M
December 31, 2017 -4.899M
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 -5.00M
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 -0.05M
December 31, 2013 0.10M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
LENZ Therapeutics, Inc. -0.395M
Impact BioMedical, Inc. 0.00
ANI Pharmaceuticals, Inc. 0.505M
Corcept Therapeutics, Inc. -9.42M
Veru, Inc. -0.001M